Anticoagulant treatment in pregnancy: study of 11 patients with heart valve prostheses
Jacovella, G.; Pace, F.; Rabitti, G.
La Clinica Terapeutica 73(2): 147-153
1975
ISSN/ISBN: 0009-9074 PMID: 1220884 Document Number: 86978
Document emailed within 1 workday
Related Documents
Tientadakul, P.; Opartkiattikul, N.; Sangtawesin, W.; Sakiyalak, P. 1997: Effect of different oral anticoagulant intensities on prothrombin fragment 1 + 2 in Thai patients with mechanical heart valve prostheses Journal of the Medical Association of Thailand 80(2): 81-86Kanaoka, Y.; Tanemoto, K.; Murakami, T.; Kuroki, K. 2000: Thromboembolic and bleeding complications in patients treated with oral anticoagulant therapy after mechanical heart valve prostheses implantation Kyobu Geka. Japanese Journal of Thoracic Surgery 53(9): 754-758
Judkiewicz, L.; Kałuzna, J.; Pajszczyk-Kieszkiewicz, T.; Pracka, H.; Moll, J.; Zasłonka, J.; Iwaszkiewicz-Zasłonkowa, A. 1979: Anticoagulant treatment of surgical and pregnant patients with heart valve prosthesis Polski Tygodnik Lekarski 34(41): 1573-1576
Tinker, J.H.; Tarhan, S. 1978: Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses. Observations in 180 operations JAMA 239(8): 738-739
Ibarra-Pérez, C.; Argüero, R. 1973: The anticoagulant management in patients with heart valve prosthesis La Prensa Medica Mexicana 38(1): 17-19
Sadeghi, H. 1987: Dysfunctions of heart valve prostheses and their surgical treatment Schweizerische Medizinische Wochenschrift 117(43): 1665-1670
Iaroshinskiĭ, I.N.; Tsukerman, G.I.; Artiukhina, T.V.; Bykova, V.A.; Fursov, B.A. 1974: Fate of heart valve biological prostheses (clinico-morphological study) Vestnik Akademii Meditsinskikh Nauk SSSR 29(6): 68-72
Kuntze, C.E.; Ebels, T.; Eijgelaar, A.; Homan van der Heide, J.N. 1989: Rates of thromboembolism with three different mechanical heart valve prostheses: randomised study Lancet 1(8637): 514-517
Tanaka, N.; Yamaguchi, T.; Ohno, T.; Kazui, T.; Ohori, K.; Kitano, I.; Abe, T.; Komatsu, S.; Wada, J. 1983: The results of long-term follow-up study for 445 cases of valve replacement with various kinds of cardiac prostheses--comparison of the clinical results among the groups using different types of valves and with or without postoperative anticoagulant therapy Nihon Kyobu Geka Gakkai 31(2): 152-160
Bendet, I.A.; Verich, N.M.; Doloman, L.B. 1987: Characteristics of the hemodynamic reactions to physical loading in patients with heart valve prostheses Kardiologiia 27(4): 104-105
Della Corte, A.; De Feo, M.; Romano, G.; Amarelli, C.; De Santo, L.S.; Nappi, G.; Scardone, M.; Cotrufo, M. 2004: Risk of warfarin anticoagulation in pregnant patients with mechanical heart valve prostheses Journal of Heart Valve Disease 13(Suppl 1): S90
Barbarash, N.A.; Tarasenko, N.P.; Belovolova, T.P.; Kovalkin, A.M.; Semenova, N.N. 1989: Erythrocytes and the assessment of the physical work capacity of patients with heart valve prostheses Fiziologiia Cheloveka 15(5): 118-122
Kolomiĭtsev, A.K.; Tereshchenko, T.L.; Kostinskiĭ, G.B.; Iatsenko, V.P.; Krivchenia, D.I. 1982: Experimental study of the polymer component with antimicrobial properties in the composition of heart valve prostheses Klinicheskaia Khirurgiia 7: 33-35
Ricci, G.; Martinelli, L.; Viganò, M.; Strozzi, C. 1988: Creatine and membrane sialic acid contents of erythrocytes in patients with heart valve prostheses Biomedicine and PharmacoTherapy 42(2): 131-132
Souto, J.C.; Zuazu-Jausoro, I.; Mateo, J.; Borrás, X.; Fontcuberta, J. 1991: Short-term treatment of thrombosis of heart valve prostheses with high doses of streptokinase. Presentation of 5 cases Medicina Clinica 96(7): 261-264
Yao, H.; Miyamoto, T.; Yamashita, K.; Mukai, M.; Wada, T.; Yamamura, M.; Nakagawa, T.; Ryomoto, M. 2000: Necessity of permanent anticoagulant therapy for isolated mitral valve replacement with bioprosthetic heart valve to prevent the postoperative thromboembolic complications Kyobu Geka. Japanese Journal of Thoracic Surgery 53(4): 337-340
Girolami, A.; Patrassi, G.M.; Schivazappa, L.; Sartori, M.T. 1993: Thrombotic and haemorrhagic complications in patients with heart valve prostheses: a more complex matter than proper prothrombin time ratios Thrombosis and Haemostasis 70(5): 878-879
De Palma, G.D.; Siciliano, S.; Sivero, L.; Galloro, G.; Donisi, M.; Catanzano, C. 1999: Impact on the quality of remaining life of treatment with self-expandable metal prostheses in patients with inoperable esophago-cardial cancer. Results of a study of 107 consecutive patients treated with Ultraflex-type prostheses Minerva Gastroenterologica E Dietologica 45(2): 95-106
Schivazappa, L.; Russo, R.; Grella, P.; Rinaldo, M.; Prandoni, P.; Zambon, G. 1981: Cardiac valve prostheses and pregnancy Bollettino Della Societa Italiana di Cardiologia 26(5): 429-433
Delahaye, J.P.; Milon, H.; Ffrench, P.; Philippe-Bert, J.; Malquarti, V.; Saradarian, W. 1985: Long-term antithrombotic treatment in patients with valve prostheses. Practical management and complications Annales de Cardiologie et d'Angeiologie 34(4): 205-211